Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer

Urology

Volumn 60, Issue 2, 2002, Pages 270-275

  Siddiqua, Ayisha ^a   Chendil, Damodaran ^a   Rowland, Randall ^a   Meigooni, Ali S ^a   Kudrimoti, Mahesh ^a   Mohiuddin, Mohammed ^a   Ahmed, Mansoor M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD SAMPLING; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; INSTRUMENTATION; MALE; METASTASIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; RNA ANALYSIS; RNA ISOLATION; TUMOR CELL;

BRACHYTHERAPY; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; IATROGENIC DISEASE; MALE; MONOCYTES; NEOPLASM CIRCULATING CELLS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036327103     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01703-X     Document Type: Article

References (27)

1. Cancer statistics, 1999
2. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
3. 125I implantation
4. I-125 interstitial implantation for prostate cancer: What have we learned 10 years later?
5. Radioisotopic implantation for carcinoma of the prostate: Does it work better than it used to?
6. 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity
7. The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: Implications for treatment optimization
8. Perineal prostatic cancer seeding following radioactive seed brachytherapy
9. Local tract metastasis of prostatic adenocarcinoma 8 years after (125)iodine brachytherapy
10. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells
11. Genomic sequence of human prostate specific antigen (PSA)
12. Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence
13. The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology
14. Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology
15. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction
16. A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team
17. The clinical usefulness of prostate specific antigen: Update 1994
18. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: A clinicopathological molecular analysis of 121 patients
19. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
20. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics
21. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy
22. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: With special reference to neoadjuvant hormonal therapy
23. Prostate cancer and radiation therapy - The message conveyed by serum prostate-specific antigen
24. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer
25. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy
26. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence
27. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer